Overview
Effects of Dexmedetomidine Used in Continuous Thoracic Paravertebral Blocks
Status:
Completed
Completed
Trial end date:
2015-09-01
2015-09-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to explore the effectiveness of dexmedetomidine as an adjunctive analgesic, used in ultrasound-guided continuous thoracic paravertebral blocks for Post-thoracotomy Pain Syndrome(PTPS).Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Weifeng TuTreatments:
Anesthetics
Dexmedetomidine
Ropivacaine
Criteria
Inclusion Criteria:1. ASA Ⅰ~Ⅲ patient undergoing thoracotomy;
2. Written informed consent from the patient or the relatives of the participating
patient.
3. BMI:18~25kg/m2
Exclusion Criteria:
1. Mental illness;
2. Epidural anesthesia or thoracic paravertebral blocks contraindicated;
3. People who have Slow-type arrhythmias or hypotension;
4. People who have lung infection or sleep apnea syndrome;
5. People who have chronic renal failure;
6. Alcohol or drug abuse;
7. Already taking gabapentin, pregabalin, benzodiazepin or antidepression drug;
8. Local anesthetics allergy;